Cyto - Histodiagnostiek SPRL

Dissolution volontaire – liquidation

Cyto - Histodiagnostiek reported total assets of 62,038 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).

Company number (CBE) 0427.146.230
2600 Antwerp
operating since 07 Sep 1984 (≈ 42 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Cyto - Histodiagnostiek shows with a free account.

See the score
Profile
SPRL since 1984
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−13,179 €
Equity−319,943 €
Cash52 €
EBITDA96,889 €
Total assets62,038 €
Solvency-515.7%

Change 2022 → 2025: Total assets 0 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Cyto - Histodiagnostiek's annual accounts

20252024202320222021
Net result−13,179 €
Equity−319,943 €
Cash52 €
EBITDA96,889 €
Total assets62,038 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 06 Jul 2026
  • Year ended 31 Dec 2024filed on 04 Sep 2025
  • Year ended 31 Dec 2023filed on 28 Jun 2024
  • Year ended 31 Dec 2022filed on 22 Jun 2023
  • Year ended 31 Dec 2021filed on 05 Jul 2022

Cyto - Histodiagnostiek's financial analysis

Management and control of Cyto - Histodiagnostiek

2 active director(s) in the register.

Cyto - Histodiagnostiek's shareholders and holdings →

Cyto - Histodiagnostiek's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0427.146.230
VAT number
No VAT activity declared to the CBE
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SPRL
Incorporated
07 Sep 1984
Registered office
2600 Antwerp
Latest accounts
2025 · filed on 06 Jul 2026

Cyto - Histodiagnostiek (SPRL) has been based in Antwerp since 1984, active in: —. For 2025, it reports a net loss of 13,179 € and equity of −319,943 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Cyto - Histodiagnostiek

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Cyto - Histodiagnostiek

What is the revenue of Cyto - Histodiagnostiek?

Cyto - Histodiagnostiek files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Cyto - Histodiagnostiek?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Cyto - Histodiagnostiek. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0427146230. Its company number (CBE) is 0427.146.230.

Where is the registered office of Cyto - Histodiagnostiek?

According to the CBE register, the registered office of Cyto - Histodiagnostiek is in 2600 Antwerp.

What is the equity of Cyto - Histodiagnostiek?

At the close of the 2025 financial year, the equity of Cyto - Histodiagnostiek amounts to -319,943 €, a solvency of -515.7% of total assets.

Who manages Cyto - Histodiagnostiek?

The register lists 2 active mandates at Cyto - Histodiagnostiek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Cyto - Histodiagnostiek

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Jul 2026

No credit card, no commitment.

What each plan unlocks →